0001385508-19-000006.txt : 20190104
0001385508-19-000006.hdr.sgml : 20190104
20190104171818
ACCESSION NUMBER: 0001385508-19-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190103
FILED AS OF DATE: 20190104
DATE AS OF CHANGE: 20190104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Toole David D
CENTRAL INDEX KEY: 0001491140
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38193
FILM NUMBER: 19511118
MAIL ADDRESS:
STREET 1: 1640 MARENGO STREET
CITY: LOS ANGELES
STATE: CA
ZIP: 90033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OPIANT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001385508
STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 SANTA MONICA BOULEVARD
STREET 2: SUITE 500
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
BUSINESS PHONE: (310) 598-5410
MAIL ADDRESS:
STREET 1: 201 SANTA MONICA BOULEVARD
STREET 2: SUITE 500
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
FORMER COMPANY:
FORMER CONFORMED NAME: Lightlake Therapeutics Inc.
DATE OF NAME CHANGE: 20091009
FORMER COMPANY:
FORMER CONFORMED NAME: Madrona Ventures, Inc.
DATE OF NAME CHANGE: 20070108
4
1
wf-form4_154664028137802.xml
FORM 4
X0306
4
2019-01-03
0
0001385508
OPIANT PHARMACEUTICALS, INC.
OPNT
0001491140
O'Toole David D
C/O OPIANT PHARMACEUTICALS, INC.
201 SANTA MONICA BOULEVARD, SUITE 500
SANTA MONICA
CA
90401
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
13.61
2019-01-03
4
A
0
33000
0
A
2029-01-02
Common Stock
33000.0
33000
D
On January 3, 2019, the reporting person was granted an option to purchase 33,000 shares of common stock. The option vests as follows: 1/48 of the options become exercisable on the first monthly anniversary of the vesting commencement date, and 1/48 of the options become exercisable on such date every month thereafter through the fourth anniversary of the Grant Date.
/s/ David D. O'Toole
2019-01-04